Goldman Sachs Downgrades Laboratory Corporation of America (LH) to Buy

Go back to Goldman Sachs Downgrades Laboratory Corporation of America (LH) to Buy

Laboratory Corporation of America (LH) PT Lowered to $165 at Barclays Following 4Q Guidance Reduction

December 3, 2018 7:39 AM EST

Barclays analyst Jack Meehan lowered the price target on Laboratory Corporation of America (NYSE: LH) to $165.00 (from $205.00) while maintaining a Overweight rating following the company's reduction in 4Q guidance.

The magnitude of the reduction so shortly after the company reduced guidance with 3Q... More

Laboratory Corporation of America (LH) PT Lowered to $155 at Deutsche Bank

November 30, 2018 12:12 PM EST

Deutsche Bank analyst Dan Leonard lowered the price target on Laboratory Corporation of America (NYSE: LH) to $155.00 (from $165.00) while maintaining a Hold rating.

... More